ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05200	Pathways in cancer	13/45	492/7206	5.76042865634e-06
ko04392	Hippo signaling pathway -multiple species	3/45	31/7206	0.000905314923257
ko05219	Bladder cancer	3/45	48/7206	0.00323503438874
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	2/45	15/7206	0.00380249787647
ko04390	Hippo signaling pathway	5/45	188/7206	0.00600796326626
ko04151	PI3K-Akt signaling pathway	7/45	390/7206	0.00983011987313
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/45	79/7206	0.012932425933
ko04512	ECM-receptor interaction	3/45	79/7206	0.012932425933
ko05212	Pancreatic cancer	3/45	83/7206	0.014768902264
ko04510	Focal adhesion	5/45	240/7206	0.0162198782061
ko04924	Renin secretion	3/45	86/7206	0.0162386529163
ko04391	Hippo signaling pathway - fly	3/45	90/7206	0.0183224601347
ko04975	Fat digestion and absorption	2/45	35/7206	0.019910334084
ko05224	Breast cancer	4/45	174/7206	0.0226707715532
ko00250	Alanine, aspartate and glutamate metabolism	2/45	38/7206	0.0232484413713
ko05146	Amoebiasis	3/45	99/7206	0.0235334451319
ko05205	Proteoglycans in cancer	5/45	271/7206	0.0259464843336
ko04520	Adherens junction	3/45	103/7206	0.0260824571874
ko01521	EGFR tyrosine kinase inhibitor resistance	3/45	106/7206	0.0280883137083
ko04015	Rap1 signaling pathway	5/45	278/7206	0.0285703511321
ko05215	Prostate cancer	3/45	111/7206	0.0316101847569
ko04750	Inflammatory mediator regulation of TRP channels	3/45	122/7206	0.0401386589396